Adjunctive Pharmacotherapy Part II.
The Christ Hospital Heart & Vascular Center, Ohio State University, USA.
Dean J
DJ
Kereiakes
D023903:Coronary Restenosis / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D000077542:Eptifibatide; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010455:Peptides / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D017410:Practice Guidelines as Topic; D000068799:Prasugrel Hydrochloride; D015607:Stents; D013876:Thiophenes / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010455:Peptides; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride; D000077542:Eptifibatide